COVID-19 kit distribution in six Latin American countries: bureaucratic autonomy, populism, and evidence-based policymaking
Clicks: 1
ID: 314581
2026
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This
article has not been analysed, so there is no overall score —
reader engagement is measured and shown alongside.
Reader Engagement
0.0
/100
1 views
0 readers
AI Quality Assessment
Not analyzed
Readership in this journal
Ranked #60 of 66 articles by views in Health policy and planning
Most read
Least read
Bar heights use a square-root scale.
Mint this article as an NFT
Not yet mintedCreate a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.
5
SUSD
one-off · no wallet required
Abstract
During the COVID-19 pandemic, governments varied widely in the extent to which policy decisions aligned with scientific evidence. We examine decision-making regarding the public distribution of COVID-19 kits containing ivermectin in six Latin American countries in 2020 and 2021, despite international scientific authorities advising against using these medicines outside of clinical trials. We focus on institutions, ideology, and interests. Theories emphasising the centrality of institutions predict that autonomous scientific institutions are more likely to resist political pressure to adopt ineffective interventions. Theories focused on ideology suggest that populist leaders may favour highly visible policy responses, including ineffective treatments, even when these diverge from expert advice. A third approach emphasises the relative power of groups favouring or opposing kit distribution. Using the comparative case study method, we analyse policy processes across Guatemala, Peru, Mexico, Costa Rica, Colombia, and Argentina. We find that neither bureaucratic autonomy, populism, nor interests alone explains policy variation. Instead, the findings are consistent with a conditional relationship in which populist leaders are more likely to favour kit distribution, but autonomous National Medicines Regulatory Agencies (NMRAs) appear to moderate the influence of populist political pressures. Countries with non-populist leaders but low institutional autonomy were also likely to distribute kits if powerful political actors favoured such policies. These findings suggest that institutional design and political context jointly shape the capacity for evidence-informed decision-making during public health emergencies. Strengthening the autonomy of regulatory agencies may help support evidence-based evaluation of emerging health technologies during future crises.
| Reference Key |
openalex_W7161935484
Use this key to autocite in the manuscript while using
SciMatic Manuscript Manager or Thesis Manager
|
|---|---|
| Authors | José Antonio Requejo Domínguez, Kevin Croke, Veronika J. Wirtz |
| Journal | Health policy and planning |
| Year | 2026 |
| DOI |
10.1093/heapol/czag069
|
| URL | |
| Keywords | Keywords not found |
Citations
No citations found. To add a citation, contact the admin at info@scimatic.org
Comments
No comments yet. Be the first to comment on this article.